Public Health Bulletin South Africa

08/06/2026

Dr Monique Muhali explains the importance of this article and why people should read it. Learn more here: https://www.phbsa.ac.za/qa-monique-muhali-ai-public-health-emergency-management/

04/06/2026

Dr Monique Muhali explains that, rather than focusing solely on technological innovation, the article highlights sustainability, governance, ethics, equity, and practical implementation within the context of existing health system challenges. Discover more insights here: https://www.phbsa.ac.za/qa-monique-muhali-ai-public-health-emergency-management/

04/06/2026

Artificial intelligence is transforming public health worldwide. In resource-constrained settings like South Africa, AI has the potential to strengthen disease surveillance, improve outbreak detection, support decision-making, and optimise healthcare resources during public health emergencies.

Our latest article explores how AI can strengthen Public Health Emergency Management while highlighting the importance of ethical governance, digital infrastructure, and workforce development for sustainable implementation. Read the full article: https://www.phbsa.ac.za/ai-public-health-emergency-management-south-africa/

22/05/2026

In this article, lead author Mr Maxwell Mabona unpacks the significance of the findings and why they matter. Explore the insights here: https://www.phbsa.ac.za/q-and-a-maxwell-mabona-imported-malaria-drug-resistance-south-africa/

20/05/2026

Mr Maxwell Mabona explains that the article explores the epidemiology and drug-resistance markers in imported and locally acquired cases. Learn more here: https://www.phbsa.ac.za/q-and-a-maxwell-mabona-imported-malaria-drug-resistance-south-africa/

19/05/2026

South Africa is among the 25 countries identified by the World Health Organization with the potential to eliminate malaria. Several challenges are still impeding elimination, including high case importation, climate, biological, and financial factors. In districts working towards elimination, infections brought in from neighbouring countries can quietly sustain transmission and introduce drug-resistant parasites.

Our latest PHBSA study compares imported and locally-acquired malaria cases in Mpumalanga and KwaZulu-Natal, using genomic surveillance to uncover differences in risk, detection, and resistance markers.

See how these insights can help target interventions and protect progress towards elimination: https://www.phbsa.ac.za/imported-locally-acquired-malaria-drug-resistance-south-africa-2022-2024/

14/05/2026

Reflecting on the importance of the session, the presenters shared:

"Today’s session focused on micro-costing as the first practical step in cost-effectiveness analysis (CEA). Before we can estimate whether the proposed intervention will improve health outcomes and be worth the cost, we need to understand what resources are being used, by whom, and at what cost. Participants worked through integrated costing sheets linking process flows, activities, staff time, consumables, capital costs, inflation adjustment, and annualisation — translating real-world programme delivery into structured economic evidence for decision-making."

- Thembekile Zwane and Leigh Johnston

14/05/2026